Status:
UNKNOWN
Chromoendoscopy in Inflammatory Bowel Disease
Lead Sponsor:
The Leeds Teaching Hospitals NHS Trust
Conditions:
Colonoscopy
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Patients with longstanding ulcerative colitis (inflammatory bowel disease, IBD) have increased risk of developing colorectal cancer (CRC) when compared with that of the general population. Therefore p...
Eligibility Criteria
Inclusion
- 1\) Patients with longstanding (more than 8 years of disease), extensive (extending proximal to splenic flexure) colitis attending for surveillance colonoscopy. 2) Patients aged over 18 years of age 3) Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease colitis.
Exclusion
- 1\) Pregnant 2) Unwilling or unable to give informed consent 3) Severe active colitis 4) Poor bowel preparation 5) Unable to reach the caecum
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03250780
Start Date
January 1 2017
End Date
January 1 2021
Last Update
June 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom, LS1 3HE,